Reprocessed Medical Devices Market to Cross the $3 Billion Mark By 2024: Fractovia Reprocessed Medical Devices Market 2018-2024: This research reviews the overall reprocessed medical devices industry, which according to a report by Global Market Insights, Inc., is growing at more than 14% CAGR during 2017 and 2024 to hit the $3bn revenue mark. Growth Drivers: • • •
Favorable regulatory landscape regarding sustainable waste disposal methods. Affordable costs coupled with the strengthening network of distributors in emerging economies. Growing use of reprocessed products in numerous cardiac surgeries and blood pressure monitoring applications.
Segmentations covered under Reprocessed Medical Devices Market Report based on Product: 1. Based on Product: Cardiovascular medical devices (Blood pressure cuffs/tourniquet cuffs, Electrophysiology cables, Cardiac stabilization and positioning devices, Diagnostic electrophysiology catheters, & Deep vein compression sleeves), Gastroenterology and urology (Gastroenterology biopsy devices, & Urology biopsy devices), Orthopedic/arthroscopic (External fixation devices), Laparoscopic (Harmonic scalpels, & Endoscopic trocars and components), & General surgery equipment (Infusion pressure bags & Balloon inflation devices) 2. Based on End-Use: Ambulatory surgical centers, Hospitals, & Clinics Key Data Points from Reprocessed Medical Devices Market Analysis: Rising prevalence of chronic diseases that further lead to upsurge in surgical procedures drives reprocessed medical devices market size during the forecast timeframe.
1|Page
Cardiovascular medical devices held maximum revenue share of the overall reprocessed medical devices market due to high prevalence of cardiovascular diseases and, associated high surgical procedures of heart. Laparoscopic segment is projected to grow lucratively owing to rising demand for minimally invasive methods coupled with increasing laparoscopic surgeries. Hospitals accounted for largest revenue share due to increasing requirement for reprocessed medical devices that aid in medical waste management. U.S. held substantial revenue share owing to rising prevalence of heart disease, supportive regulatory framework, high number of medical products producers involved in the reprocessing programs.
U.S. Reprocessed Medical Devices Market, By Product, 2013 – 2024 (USD Million)
Regional Data Coverage under Reprocessed Medical Devices Market: 1. 2. 3. 4. 5.
North America (U.S. & Canada) Asia Pacific (China, India, Japan & Australia) Europe (UK, Germany, France, Spain, Italy, Poland & Russia) Latin America (Argentina, Brazil, & Mexico) Middle East & Africa (Saudi Arabia, UAE & South Africa)
Key Company Profiled in this Research Report: Centurion Medical Products Corp., GE Healthcare, Hygia Health Services, Medline ReNewal, Midwest Reprocessing Centre, ReNu Medical Inc, Siemens Healthcare, Soma Technology, 2|Page
Steril Med Inc., Medtronic, Stryker Sustainability, SureTek Medical, Vanguard AG., Pioneer Medical Devices AG, Steripro Canada Inc. & Vascular Solutions, Inc. (Now Teleflex). Key Chapters Covered: • • • • • •
Methodology Executive Summary Reprocessed Medical Devices Industry Insights Reprocessed Medical Devices Market, By Product Reprocessed Medical Devices Market, By Region Company Profiles
3|Page
Table of Content of Reprocessed Medical Devices Market: Chapter 1. Methodology 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition and forecast parameters 1.2. Data sources 1.2.1. Secondary 1.2.2. Primary Chapter 2. Executive Summary 2.1. Reprocessed medical devices industry 3600 synopsis, 2013 - 2024 2.1.1. Business trends 2.1.2. Product trends 2.1.3. End-use trends 2.1.4. Regional trends Chapter 3. Reprocessed medical devices Industry Insights 3.1. Industry segmentation 3.2. Industry landscape, 2013 – 2024 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Favorable regulatory landscape regarding sustainable waste disposal methods 4|Page
3.3.1.2. Affordable costs coupled with the strengthening network of distributors in emerging economies 3.3.1.3. Growing use of reprocessed products in numerous cardiac surgeries and blood pressure monitoring applications 3.3.2. Industry pitfalls & challenges 3.3.2.1. Risk of surgical site infections 3.4. Growth potential analysis 3.4.1. By product 3.4.2. By end-use 3.5. Regulatory landscape 3.5.1. U.S 3.5.2. Europe 3.5.3. Japan 3.6. Porter’s analysis 3.7. Competitive landscape, 2016 3.7.1. Business overview 3.7.2. Revenue analysis 3.7.3. Product landscape 3.7.4. Strategy dashboard 3.8. PESTEL analysis Chapter 4. Reprocessed Medical Devices Market, By Product 4.1. Reprocessed medical devices market share, by product, 2016 & 2024 4.2. Cardiovascular medical devices 4.2.1. Market estimates and forecast, by region, 2013 – 2024 5|Page
4.2.2. Blood pressure cuffs/tourniquet cuffs 4.2.2.1. Market estimates and forecast, by region, 2013 – 2024 4.2.3. Electrophysiology cables 4.2.3.1. Market estimates and forecast, by region, 2013 – 2024 4.2.4. Cardiac stabilization and positioning devices 4.2.4.1. Market estimates and forecast, by region, 2013 – 2024 4.2.5. Diagnostic electrophysiology catheters 4.2.5.1. Market estimates and forecast, by region, 2013 – 2024 4.2.6. Deep vein compression sleeves (DVT) 4.2.6.1. Market estimates and forecast, by region, 2013 – 2024 4.3. Gastroenterology and urology 4.3.1. Market estimates and forecast, by region, 2013 – 2024 4.3.2. Gastroenterology biopsy devices 4.3.2.1. Market estimates and forecast, by region, 2013 – 2024 4.3.3. Urology biopsy devices 4.3.3.1. Market estimates and forecast, by region, 2013 – 2024 4.4. Orthopedic/arthroscopic 4.4.1. Market estimates and forecast, by region, 2013 – 2024 4.4.2. External fixation devices 4.4.2.1. Market estimates and forecast, by region, 2013 – 2024 4.5. Laparoscopic 4.5.1. Market estimates and forecast, by region, 2013 – 2024 4.5.2. Harmonic scalpels 6|Page
4.5.2.1. Market estimates and forecast, by region, 2013 – 2024 4.5.3. Endoscopic trocars and components 4.5.3.1. Market estimates and forecast, by region, 2013 – 2024 4.6. General surgery equipment 4.6.1. Market estimates and forecast, by region, 2013 – 2024 4.6.2. Infusion pressure bags 4.6.2.1. Market estimates and forecast, by region, 2013 – 2024 4.6.3. Balloon inflation devices 4.6.3.1. Market estimates and forecast, by region, 2013 – 2024 Chapter 5. Reprocessed Medical Devices Market, By End-use 5.1. Reprocessed medical devices market share, by end-use, 2016 & 2024 5.2. Ambulatory surgical centers 5.2.1. Market estimates and forecast, by region, 2013 – 2024 5.3. Hospitals 5.3.1. Market estimates and forecast, by region, 2013 – 2024 5.4. Clinics 5.4.1. Market estimates and forecast, by region, 2013 – 2024 Chapter 6. Reprocessed Medical Devices Market, By Region 6.1. Reprocessed medical devices market share, by region, 2016 & 2024 6.2. North America 6.2.1. Market estimates and forecast, by country, 2013 – 2024 6.2.2. Market estimates and forecast, by product, 2013 – 2024 6.2.3. Market estimates and forecast, by end-use, 2013 – 2024 7|Page
6.2.4. U.S. 6.2.4.1. Market estimates and forecast, by product, 2013 – 2024 6.2.4.2. Market estimates and forecast, by end-use, 2013 – 2024 6.2.5. Canada 6.2.5.1. Market estimates and forecast, by product, 2013 – 2024 6.2.5.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3. Europe 6.3.1. Market estimates and forecast, by country, 2013 – 2024 6.3.2. Market estimates and forecast, by product, 2013 – 2024 6.3.3. Market estimates and forecast, by end-use, 2013 – 2024 6.3.4. Germany 6.3.4.1. Market estimates and forecast, by product, 2013 – 2024 6.3.4.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.5. UK 6.3.5.1. Market estimates and forecast, by product, 2013 – 2024 6.3.5.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.6. France 6.3.6.1. Market estimates and forecast, by product, 2013 – 2024 6.3.6.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.7. Spain 6.3.7.1. Market estimates and forecast, by product, 2013 – 2024 6.3.7.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.8. Italy 8|Page
6.3.8.1. Market estimates and forecast, by product, 2013 – 2024 6.3.8.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.9. Russia 6.3.9.1. Market estimates and forecast, by product, 2013 – 2024 6.3.9.2. Market estimates and forecast, by end-use, 2013 – 2024 6.3.10. Poland 6.3.10.1. Market estimates and forecast, by product, 2013 – 2024 6.3.10.2. Market estimates and forecast, by end-use, 2013 – 2024 6.4. Asia Pacific 6.4.1. Market estimates and forecast, by country, 2013 – 2024 6.4.2. Market estimates and forecast, by product, 2013 – 2024 6.4.3. Market estimates and forecast, by end-use, 2013 – 2024 6.4.4. China 6.4.4.1. Market estimates and forecast, by product, 2013 – 2024 6.4.4.2. Market estimates and forecast, by end-use, 2013 – 2024 6.4.5. India 6.4.5.1. Market estimates and forecast, by product, 2013 – 2024 6.4.5.2. Market estimates and forecast, by end-use, 2013 – 2024 6.4.6. Japan 6.4.6.1. Market estimates and forecast, by product, 2013 – 2024 6.4.6.2. Market estimates and forecast, by end-use, 2013 – 2024 6.4.7. Australia 6.4.7.1. Market estimates and forecast, by product, 2013 – 2024 9|Page
6.4.7.2. Market estimates and forecast, by end-use, 2013 – 2024 6.5. Latin America 6.5.1. Market estimates and forecast, by country, 2013 – 2024 6.5.2. Market estimates and forecast, by product, 2013 – 2024 6.5.3. Market estimates and forecast, by end-use, 2013 – 2024 6.5.4. Argentina 6.5.4.1. Market estimates and forecast, by product, 2013 – 2024 6.5.4.2. Market estimates and forecast, by end-use, 2013 – 2024 6.5.5. Brazil 6.5.5.1. Market estimates and forecast, by product, 2013 – 2024 6.5.5.2. Market estimates and forecast, by end-use, 2013 – 2024 6.5.6. Mexico 6.5.6.1. Market estimates and forecast, by product, 2013 – 2024 6.5.6.2. Market estimates and forecast, by end-use, 2013 – 2024 6.6. Middle East & Africa 6.6.1. Market estimates and forecast, by country, 2013 – 2024 6.6.2. Market estimates and forecast, by product, 2013 – 2024 6.6.3. Market estimates and forecast, by end-use, 2013 – 2024 6.6.4. Saudi Arabia 6.6.4.1. Market estimates and forecast, by product, 2013 – 2024 6.6.4.2. Market estimates and forecast, by end-use, 2013 – 2024 6.6.5. South Africa 6.6.5.1. Market estimates and forecast, by product, 2013 – 2024 10 | P a g e
6.6.5.2. Market estimates and forecast, by end-use, 2013 – 2024 6.6.6. UAE 6.6.6.1. Market estimates and forecast, by product, 2013 – 2024 6.6.6.2. Market estimates and forecast, by end-use, 2013 – 2024 Chapter 7. Company Profiles 7.1. Centurion Medical Products Corp. 7.1.1. Business overview 7.1.2. Financial data 7.1.3. Product landscape 7.1.4. Strategic outlook 7.1.5. SWOT analysis 7.2. GE Healthcare 7.2.1. Business overview 7.2.2. Financial data 7.2.3. Product landscape 7.2.4. Strategic outlook 7.2.5. SWOT analysis 7.3. Hygia Health Services 7.3.1. Business overview 7.3.2. Financial data 7.3.3. Product landscape 7.3.4. Strategic outlook 7.3.5. SWOT analysis 11 | P a g e
7.4. Medline ReNewal 7.4.1. Business overview 7.4.2. Financial data 7.4.3. Product landscape 7.4.4. Strategic outlook 7.4.5. SWOT analysis 7.5. Midwest Reprocessing Centre 7.5.1. Business overview 7.5.2. Financial data 7.5.3. Product landscape 7.5.4. Strategic outlook 7.5.5. SWOT analysis 7.6. ReNu Medical Inc 7.6.1. Business overview 7.6.2. Financial data 7.6.3. Product landscape 7.6.4. Strategic outlook 7.6.5. SWOT analysis 7.7. Siemens Healthcare 7.7.1. Business overview 7.7.2. Financial data 7.7.3. Product landscape 7.7.4. Strategic outlook 12 | P a g e
7.7.5. SWOT analysis 7.8. Soma Technology 7.8.1. Business overview 7.8.2. Financial data 7.8.3. Product landscape 7.8.4. Strategic outlook 7.8.5. SWOT analysis 7.9. Steril Med Inc. (Ethicon Endo-Surgery, Inc.) 7.9.1. Business overview 7.9.2. Financial data 7.9.3. Product landscape 7.9.4. Strategic outlook 7.9.5. SWOT analysis 7.10. Medtronic 7.10.1. Business overview 7.10.2. Financial data 7.10.3. Product landscape 7.10.4. Strategic outlook 7.10.5. SWOT analysis 7.11. Stryker Sustainability 7.11.1. Business overview 7.11.2. Financial data 7.11.3. Product landscape 13 | P a g e
7.11.4. Strategic outlook 7.11.5. SWOT analysis 7.12. SureTek Medical 7.12.1. Business overview 7.12.2. Financial data 7.12.3. Product landscape 7.12.4. Strategic outlook 7.12.5. SWOT analysis 7.13. Vanguard AG. 7.13.1. Business overview 7.13.2. Financial data 7.13.3. Product landscape 7.13.4. Strategic outlook 7.13.5. SWOT analysis 7.14. Pioneer Medical Devices AG 7.14.1. Business overview 7.14.2. Financial data 7.14.3. Product landscape 7.14.4. Strategic outlook 7.14.5. SWOT analysis 7.15. Steripro Canada Inc. 7.15.1. Business overview 7.15.2. Financial data 14 | P a g e
7.15.3. Product landscape 7.15.4. Strategic outlook 7.15.5. SWOT analysis 7.16. Vascular Solutions, Inc. (Now Teleflex) 7.16.1. Business overview 7.16.2. Financial data 7.16.3. Product landscape 7.16.4. Strategic outlook 7.16.5. SWOT analysis About Fractovia.org: Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a predetermined word-based theme, offering important connections to readers and clients, as well as distributors.
Contact Us: Arun Hegde Corporate Sales, USA Fractovia.org Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@fractovia.org Website: https://www.fractovia.org Connect with us: Facebook | Twitter
15 | P a g e